Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism

R. Cesareo; Enrico Di Stasio; F. Vescini; G. Campagna; R. Cianni; V. Pasqualini; F. Romitelli; F. Grimaldi; S. Manfrini; A. Palermo

doi:10.1007/s00198-014-3000-2

Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism

R. Cesareo, Enrico Di Stasio, F. Vescini, G. Campagna, R. Cianni, V. Pasqualini, F. Romitelli, F. Grimaldi, S. Manfrini, A. Palermo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

29 Citazioni (Scopus)

Abstract

No data on the pharmacological treatment of normocalcemic hyperparathyroidism (NPHPT) are available. We treated 30 NPHPT postmenopausal women with alendronate/cholecalciferol (treated group) or vitamin D alone (control group). Over 1 year, bone mineral density (BMD) increased significantly in treated group, but not in control group. Both treatments did not affect serum or urinary calcium.

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	Osteoporosis International
DOI	https://doi.org/10.1007/s00198-014-3000-2
Stato di pubblicazione	Pubblicato - 2014

Keywords

Vitamin D

Accesso al documento

10.1007/s00198-014-3000-2

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{fd7409c19a244b1393f94a83f42c9338,

title = "Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism",

abstract = "No data on the pharmacological treatment of normocalcemic hyperparathyroidism (NPHPT) are available. We treated 30 NPHPT postmenopausal women with alendronate/cholecalciferol (treated group) or vitamin D alone (control group). Over 1 year, bone mineral density (BMD) increased significantly in treated group, but not in control group. Both treatments did not affect serum or urinary calcium.",

keywords = "Vitamin D, Vitamin D",

author = "R. Cesareo and {Di Stasio}, Enrico and F. Vescini and G. Campagna and R. Cianni and V. Pasqualini and F. Romitelli and F. Grimaldi and S. Manfrini and A. Palermo",

year = "2014",

doi = "10.1007/s00198-014-3000-2",

language = "English",

pages = "N/A--N/A",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism

AU - Cesareo, R.

AU - Di Stasio, Enrico

AU - Vescini, F.

AU - Campagna, G.

AU - Cianni, R.

AU - Pasqualini, V.

AU - Romitelli, F.

AU - Grimaldi, F.

AU - Manfrini, S.

AU - Palermo, A.

PY - 2014

Y1 - 2014

N2 - No data on the pharmacological treatment of normocalcemic hyperparathyroidism (NPHPT) are available. We treated 30 NPHPT postmenopausal women with alendronate/cholecalciferol (treated group) or vitamin D alone (control group). Over 1 year, bone mineral density (BMD) increased significantly in treated group, but not in control group. Both treatments did not affect serum or urinary calcium.

AB - No data on the pharmacological treatment of normocalcemic hyperparathyroidism (NPHPT) are available. We treated 30 NPHPT postmenopausal women with alendronate/cholecalciferol (treated group) or vitamin D alone (control group). Over 1 year, bone mineral density (BMD) increased significantly in treated group, but not in control group. Both treatments did not affect serum or urinary calcium.

KW - Vitamin D

UR - http://hdl.handle.net/10807/64746

U2 - 10.1007/s00198-014-3000-2

DO - 10.1007/s00198-014-3000-2

M3 - Article

SN - 0937-941X

SP - N/A-N/A

JO - Osteoporosis International

JF - Osteoporosis International

ER -

Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo